Colin N. Young, Associate Professor, joined the faculty of the Department of Pharmacology and Physiology in January 2015. Prior to moving to GWU, Dr. Young earned his Bachelor’s and Master’s degrees in Exercise Science from the University of Delaware and completed his doctoral work in Physiology at the University of Missouri. During this time his research focused on neural cardiovascular control in both healthy and clinical human populations, including diabetic, chronic kidney disease, and obese patients. With the desire to gain additional experience across the realm of translational research, Colin pursued postdoctoral training at Cornell University where he employed an array of functional genomics techniques in murine models of cardiometabolic disease. Dr. Young’s current research is focused on deciphering the central nervous system mechanisms that contribute to the development of cardiovascular (e.g., hypertension) and metabolic (e.g., obesity) disorders. His approach encompasses a wide-range of genetic/molecular strategies, advanced in vivo imaging techniques, state-of-the art neuroscience approaches, and whole animal cardiovascular and metabolic physiology. In addition to his scholarly work, Dr. Young also serves as the Co-Director of the GW Institute for Biomedical Sciences Pharmacology & Physiology Graduate Program, and serves on numerous institutional and national committees focused on research endeavors as well as initiatives to enhance opportunities for STEM trainees across all populations.